A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

NCT00628680 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

415

Enrollment

INDUSTRY

Sponsor class

Conditions

End Stage Renal Disease

Interventions

DEVICE: AAT-023 solution (Zuragen)
DRUG: Heparin

Sponsor

Ash Access Technology